Skip to main content
Top
Published in: BMC Ophthalmology 1/2014

Open Access 01-12-2014 | Research article

Oxidant/antioxidant state in tissue of prymary and recurrent pterygium

Authors: Alexandre Kormanovski, Fidelina Parra, Adriana Jarillo-Luna, Eleazar Lara-Padilla, Judith Pacheco-Yépez, Rafael Campos-Rodriguez

Published in: BMC Ophthalmology | Issue 1/2014

Login to get access

Abstract

Background

Pterygium is a disorder of the ocular surface induced by chronic exposure to UV-light. Abundant data is available from patients with primary pterygium, but scarce from those with recurrent pterygium. The present study aimed to explore the oxidant/antioxidant status in tissue of primary and recurrent pterigium in men and women.

Methods

Pathological tissue samples were taken during surgery on patients with primary and recurrent pterygium. Healthy conjunctive tissue samples were taken during cataract surgery. After homogenization of 77 tissue samples, evaluation was made of thiobarbituric reactive substances (TBARS), nitric oxide (NO), total antioxidant status (TAS) and the activity of the three main antioxidant enzymes: glutathione peroxidase, superoxide dismutase and catalase. Gender differences were evaluated.

Results

Compared to the control group, in the primary pterygium group there was an increase in NO and TAS, and a tendency to a decrease of all antioxidant enzymes, indicating an increase in non-enzymatic antioxidant activity. Compared to the control group, in the recurrent pterygium group there was a significant decrease in the level of TAS and antioxidant enzymes. A high positive correlation was found between most of measured parameters within the control group and the recurrent pterygium group, but not within the primary pterygium group. Compared to men, a significant difference was observed in the elevated NO level and low TAS level of women in the prymary pterygium group.

Conclusions

The diminished antioxidant defense in the recurrent pterygium group, possibly determined mainly by decreased non-enzymatic activity, supports the idea that oxidative stress plays an important role in the recurrence of this disorder.
Appendix
Available only for authorised users
Literature
1.
go back to reference Demir Ü, Demir T, Ilhan N: The protective effect of alpha-lipoic acid against oxidative damage in rabbit conjunctiva and cornea exposed to ultraviolet radiation. Ophthalmologica. 2005, 219: 49-53. 10.1159/000081783.CrossRefPubMed Demir Ü, Demir T, Ilhan N: The protective effect of alpha-lipoic acid against oxidative damage in rabbit conjunctiva and cornea exposed to ultraviolet radiation. Ophthalmologica. 2005, 219: 49-53. 10.1159/000081783.CrossRefPubMed
2.
go back to reference Jarrett SG, Lewin AS, Boulton ME: The importance of mitochondria in age-related and inherited eye disorders. Ophthalmic Res. 2010, 44: 179-190. 10.1159/000316480.CrossRefPubMedPubMedCentral Jarrett SG, Lewin AS, Boulton ME: The importance of mitochondria in age-related and inherited eye disorders. Ophthalmic Res. 2010, 44: 179-190. 10.1159/000316480.CrossRefPubMedPubMedCentral
3.
go back to reference Rose RC, Richer SP, Bode AM: Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med. 1998, 217: 397-407. 10.3181/00379727-217-44250.CrossRefPubMed Rose RC, Richer SP, Bode AM: Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med. 1998, 217: 397-407. 10.3181/00379727-217-44250.CrossRefPubMed
4.
go back to reference Shoham A, Hadziahmetovic M, Dunaief J, Mydlarski MB, Schipper HM: Oxidative stress in diseases of the human cornea. Free Radic Biol Med. 2008, 45: 1047-1055. 10.1016/j.freeradbiomed.2008.07.021.CrossRefPubMed Shoham A, Hadziahmetovic M, Dunaief J, Mydlarski MB, Schipper HM: Oxidative stress in diseases of the human cornea. Free Radic Biol Med. 2008, 45: 1047-1055. 10.1016/j.freeradbiomed.2008.07.021.CrossRefPubMed
5.
go back to reference Saccá SC, Roszkowska AM, Izzotti A: Environmental and endogenous antioxidants as the main determinants of non-cancer ocular diseases. Mutat Res. 2013, 752: 153-171. 10.1016/j.mrrev.2013.01.001.CrossRefPubMed Saccá SC, Roszkowska AM, Izzotti A: Environmental and endogenous antioxidants as the main determinants of non-cancer ocular diseases. Mutat Res. 2013, 752: 153-171. 10.1016/j.mrrev.2013.01.001.CrossRefPubMed
6.
go back to reference Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR: The science of pterygia. Br J Ophthalmol. 2010, 94: 815-820. 10.1136/bjo.2008.151852.CrossRefPubMed Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR: The science of pterygia. Br J Ophthalmol. 2010, 94: 815-820. 10.1136/bjo.2008.151852.CrossRefPubMed
7.
go back to reference Dushku N, Reid TW: P53 expression in altered limbal cells of pingueculae, pterygia, and limbar tumors. Curr Eye Res. 1997, 16: 1179-1192. 10.1076/ceyr.16.12.1179.5036.CrossRefPubMed Dushku N, Reid TW: P53 expression in altered limbal cells of pingueculae, pterygia, and limbar tumors. Curr Eye Res. 1997, 16: 1179-1192. 10.1076/ceyr.16.12.1179.5036.CrossRefPubMed
8.
go back to reference Weinstein O, Rosental G, Zirkin H, Monos T, Lifshitz T, Agrov S: Overexpression of p53 tumor suppressor gene in pterygia. Eye. 2002, 16: 619-621. 10.1038/sj.eye.6700150.CrossRefPubMed Weinstein O, Rosental G, Zirkin H, Monos T, Lifshitz T, Agrov S: Overexpression of p53 tumor suppressor gene in pterygia. Eye. 2002, 16: 619-621. 10.1038/sj.eye.6700150.CrossRefPubMed
9.
go back to reference Nolan TM, Di Girolamo N, Coroneo MT, Wakefield D: Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts. Invest Ophthalmol Vis Sci. 2004, 45: 110-113. 10.1167/iovs.03-0046.CrossRefPubMed Nolan TM, Di Girolamo N, Coroneo MT, Wakefield D: Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts. Invest Ophthalmol Vis Sci. 2004, 45: 110-113. 10.1167/iovs.03-0046.CrossRefPubMed
10.
go back to reference Detorakis ET, Sourvinos G, Spandidos DA: Detection of herpes simplex virus and human papiloma virus in ophthalmic pterygium. Cornea. 2001, 20: 164-167. 10.1097/00003226-200103000-00010.CrossRefPubMed Detorakis ET, Sourvinos G, Spandidos DA: Detection of herpes simplex virus and human papiloma virus in ophthalmic pterygium. Cornea. 2001, 20: 164-167. 10.1097/00003226-200103000-00010.CrossRefPubMed
11.
go back to reference Chen KH, Hsu WM, Cheng CC, Li YS: Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol. 2003, 87: 1046-1048. 10.1136/bjo.87.8.1046.CrossRefPubMedPubMedCentral Chen KH, Hsu WM, Cheng CC, Li YS: Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol. 2003, 87: 1046-1048. 10.1136/bjo.87.8.1046.CrossRefPubMedPubMedCentral
12.
go back to reference Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Lin CL, Chang KC: Oxidative DNA damage in pterygium. Mol Vis. 2005, 11: 71-75.PubMed Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Lin CL, Chang KC: Oxidative DNA damage in pterygium. Mol Vis. 2005, 11: 71-75.PubMed
13.
go back to reference Kau HC, Tsai CC, Lee CF, Kao SC, Hsu WM, Liu JH, Wei YH: Increased oxidative DNA damage, 8-hydroxydeoxyguanosine, in human pterygium. Eye. 2006, 2: 826-831.CrossRef Kau HC, Tsai CC, Lee CF, Kao SC, Hsu WM, Liu JH, Wei YH: Increased oxidative DNA damage, 8-hydroxydeoxyguanosine, in human pterygium. Eye. 2006, 2: 826-831.CrossRef
14.
go back to reference Özdemir G, Inanc F, Kilinc M: Investigation of nitric oxide in pterygium. Can J Ophthalmol. 2005, 40: 743-746. 10.1016/S0008-4182(05)80092-4.CrossRefPubMed Özdemir G, Inanc F, Kilinc M: Investigation of nitric oxide in pterygium. Can J Ophthalmol. 2005, 40: 743-746. 10.1016/S0008-4182(05)80092-4.CrossRefPubMed
15.
go back to reference Uҫakhan OO, Kanpolat A, Elgün S, Durak I: The role of oxidative mechanisms in the etiopathogenesis of pterygium: a preliminary study. Ophthalmologica. 2009, 223: 41-46. 10.1159/000167020.CrossRef Uҫakhan OO, Kanpolat A, Elgün S, Durak I: The role of oxidative mechanisms in the etiopathogenesis of pterygium: a preliminary study. Ophthalmologica. 2009, 223: 41-46. 10.1159/000167020.CrossRef
16.
go back to reference Balci M, Şahin Ş, Mutlu F, Yağci R, Karanci P, Yildiz M: Investigation of oxidative stress in pterygium tissue. Mol Vis. 2011, 17: 443-447.PubMedPubMedCentral Balci M, Şahin Ş, Mutlu F, Yağci R, Karanci P, Yildiz M: Investigation of oxidative stress in pterygium tissue. Mol Vis. 2011, 17: 443-447.PubMedPubMedCentral
17.
go back to reference Karahan N, Baspinar S, Ciris M, Baydar CL, Kapucuoglu N: Cyclooxygenase-2 expression in primary and recurrent pterygium. Indian J Ophthalmol. 2008, 56: 279-283. 10.4103/0301-4738.39663.CrossRefPubMedPubMedCentral Karahan N, Baspinar S, Ciris M, Baydar CL, Kapucuoglu N: Cyclooxygenase-2 expression in primary and recurrent pterygium. Indian J Ophthalmol. 2008, 56: 279-283. 10.4103/0301-4738.39663.CrossRefPubMedPubMedCentral
18.
go back to reference Ismaeel OM, Jaafar H, Ibrahim M: Detection of 8 -hydroxydeoxyguanosine enzyme in recurrent pterygium raising a question on its role on recurrence. Int J Ophthalmol. 2010, 3: 245-248.PubMedPubMedCentral Ismaeel OM, Jaafar H, Ibrahim M: Detection of 8 -hydroxydeoxyguanosine enzyme in recurrent pterygium raising a question on its role on recurrence. Int J Ophthalmol. 2010, 3: 245-248.PubMedPubMedCentral
19.
go back to reference Di Girolamo N, Wakefield D, Coroneo MT: UV-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci. 2006, 47: 2430-2437. 10.1167/iovs.05-1130.CrossRefPubMed Di Girolamo N, Wakefield D, Coroneo MT: UV-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci. 2006, 47: 2430-2437. 10.1167/iovs.05-1130.CrossRefPubMed
20.
go back to reference Blades KJ, Patel S, Aidoo KE: Oral antioxidant therapy for marginal dry eye. Eur J Clin Nutr. 2001, 55: 589-597. 10.1038/sj.ejcn.1601186.CrossRefPubMed Blades KJ, Patel S, Aidoo KE: Oral antioxidant therapy for marginal dry eye. Eur J Clin Nutr. 2001, 55: 589-597. 10.1038/sj.ejcn.1601186.CrossRefPubMed
21.
go back to reference Hicks JJ, Medina-Navarro R: Inhibitory capacity of human serum on induced microsomal lipoperoxidation. Arch Med Res. 1995, 26: 169-172.PubMed Hicks JJ, Medina-Navarro R: Inhibitory capacity of human serum on induced microsomal lipoperoxidation. Arch Med Res. 1995, 26: 169-172.PubMed
22.
go back to reference Lee DH, Cho HJ, Kim JT, Choi JO, Joo CK: Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea. 2001, 20: 738-742. 10.1097/00003226-200110000-00013.CrossRefPubMed Lee DH, Cho HJ, Kim JT, Choi JO, Joo CK: Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea. 2001, 20: 738-742. 10.1097/00003226-200110000-00013.CrossRefPubMed
23.
go back to reference Prorock AJ, Hafezi-Moghadam A, Laubach VE, Liau JK, Ley K: Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2003, 284: H133-H140.CrossRefPubMed Prorock AJ, Hafezi-Moghadam A, Laubach VE, Liau JK, Ley K: Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2003, 284: H133-H140.CrossRefPubMed
24.
go back to reference Ang LP, Chua JL, Tan DT: Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol. 2007, 18: 308-313. 10.1097/ICU.0b013e3281a7ecbb.CrossRefPubMed Ang LP, Chua JL, Tan DT: Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol. 2007, 18: 308-313. 10.1097/ICU.0b013e3281a7ecbb.CrossRefPubMed
Metadata
Title
Oxidant/antioxidant state in tissue of prymary and recurrent pterygium
Authors
Alexandre Kormanovski
Fidelina Parra
Adriana Jarillo-Luna
Eleazar Lara-Padilla
Judith Pacheco-Yépez
Rafael Campos-Rodriguez
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2014
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/1471-2415-14-149

Other articles of this Issue 1/2014

BMC Ophthalmology 1/2014 Go to the issue